Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arvisol (cannabidiol) in adults with IBS-D
2024-514685-39-00Phase 2Completed
- Sponsor
- Cannabibs
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of cannabidiol in Diarrhea-predominant irritable bowel syndrome (IBS-D), sponsored by Cannabibs. Primary endpoints: Safety, Change in gastrointestinal symptom scores and 1 more. Started Feb 2025; status: completed.
02
Drugs
cannabidiol
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on 2024-514685-39-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514685-39-00.